Spontaneous bacterial peritonitis: How to deal with this life-threatening cirrhosis complication?

Therapeutics and Clinical Risk Management

Volumn 4, Issue 5, 2008, Pages 919-925

  Ribeiro, Tarsila C R ^a,d   Chebli, Julio M F ^b   Kondo, Mario ^a   Gaburri, Pedro Duarte ^c   Chebli, Liliana Andrade ^b   Feldner, Ana Cristina Amaral ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^c Liver Unit   (Brazil)

^d NONE   (Brazil)

Author keywords

Ascites; Cirrhosis; Diagnosis; Peritonitis; Treatment

Indexed keywords

ALBUMIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE; TOBRAMYCIN; TUMOR NECROSIS FACTOR ANTIBODY;

ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ASCITES FLUID CYTOLOGY; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; BLOOD CULTURE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; DOSAGE SCHEDULE COMPARISON; DRUG CHOICE; DRUG EFFICACY; EARLY DIAGNOSIS; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; MULTIDRUG RESISTANCE; NEUTROPHIL COUNT; NONHUMAN; PARACENTESIS; PATHOGENESIS; RECOMMENDED DRUG DOSE; REVIEW; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; TEST STRIP; URINARY TRACT INFECTION;

EID: 56749115785     PISSN: 11766336     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (85)

1. Almeida PR, Camargo NS, Arenz M et al. 2007. Spontaneous bacterial peritonitis: impact of microbiological changes. Arq Gastroenterol, 44:68-72.
2. Andreu M, Sola R, Sitges-Serra A, et al. 1993. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology, 104:1133-8.
3. Angeloni S, Nicolini G, Merli M, et al. 2003. Validation of automated blood cell counter for the determination of polymorphonuclear cell count in the ascitic fluid of cirrhotic patients with or without spontaneous bacterial peritonitis. Am J Gastroenterol, 98:1844-8.
4. Azoulay E, Fartouk M, Galliot R, et al. 2000. Rapid diagnosis of infectious pleural effusions by use of reagent strips. Clin Infect Dis, 31:914-19.
5. Bass NM. 1999. Intravenous albumin for spontaneous bacterial peritonitis in patients with cirrhosis. N Engl J Med, 341:443-4.
6. Bauer TM, Steinbruckner B, Brinkmann FE, et al. 2001. Small intestinal bacterial overgrowth in patients with cirrhosis. Prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol, 96:2962-7.
7. Bernard B, Grange JD, Khac EN, et al. 1999. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis. Hepatology, 29:1655-61.
8. Braga LLBC, Souza MHLP, Barbosa AMC, et al. 2006. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients in northeastern Brazil by use of rapid urine-screening test. Sao Paulo Med J, 24:141-4.
9. Brule M, Hillemand P, Goutner B. 1939. Septicemie a colibacille et peritonite termina]e chez une cirrhotique. Bull Soc Med Hop Paris, 63:1167.
10. Cachin M. 1955. [Sur un syndrome ictero-ascitique avec colibacillemie.] Rev Med Chir Mal Foie, 30:5.
11. Caroli J, Platteborse R. 1956. [Septicemie porto-cave. Cirrhoses du foie et septicemie a colibacille.] Sem Hop Paris, 34:112-27.
12. Castellote J, Girbau A, Maisterra S, et al. 2008. Spontaneous bacterial peritonitis and bacterascites prevalence in asymptomatic cirrhotic outpatients undergoing large-volume paracentesis. J Gastroenterol Hepatol, 23:256-9.
13. Castellote J, López C, Gornals J, et al. 2003. Rapid diagnosis of spontaneous bacterial peritonitis by use of reagent strips. Hepatology, 37:893-6.
14. Castellote J, Lopez C, Gornals J, et al. 2005. Use of reagent strips for the rapid diagnosis of spontaneous bacterial empyema. J Clin Gastroenterol, 39:278-81.
15. Chang CS, Chen GH, Lien HC, et al. 1998. Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology, 28:1187-90.
16. Cholongitas E, Papatheodoridis GV, Lahanas A, et al. 2005. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int, 25:57-61.
17. Christou L, Pappas G, Falagas ME. 2007. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol, 102:1510-17.
18. Cirera I, Bauer TM, Navasa M, et al. 2001. Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol, 34:32-7.
19. Conn HO. 1964. Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome. Ann Intern Med, 60:568-80.
20. Coral G, Mattos AA, Damo DF, et al. 2002. [Prevalência e prognóstico da peritonite bacteriana espontânea. Experiência em pacientes internados em um hospital geral de Porto Alegre, RS, Brasil (1991-2000).] Arq Gastroenterol, 39:158-62.
21. Devillé WL, Yzermans JC, van Duijn NP, et al. 2004. The urine dipstick test useful to rule out infections. A meta analysis of the accuracy. BMC Urology, 4:4.
22. Evans LT, Kim WR, Poterucha JJ, et al. 2003. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology, 37:897-901.
23. Felisart J, Rimola A, Arroyo V, et al. 1985. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology, 5:457-62.
24. Fernández J, Navasa M, Gomez J, et al. 2002. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology, 35:140-8.
25. Fernández J, Navasa M, Planas R, et al. 2007. Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis. Gastroenterology, 133:818-24.
26. Fernández J, Ruiz del Arbol L, Gómez C, et al. 2006. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage. Gastroenterology, 131:1049-56.
27. Figueiredo FAF, Coelho HSM, Soares JAS. 1999. [Peritonite bacteriana espontânea na cirrose hepática: prevalência, fatores preditivos e prognóstico.] Rev Ass Med Brasil, 45:128-36.
28. Francés R, Chiva M, Sánchez E, et al. 2007. Bacterial translocation is downregulated by anti-TNF-a monoclonal antibody administration in rats with cirrhosis and ascites. J Hepatol, 46:797-803.
29. Frazee LA, Marinos AE, Rybarczk AM, et al. 2005. Long-term prophylaxis of spontaneous bacterial peritonitis in patients with cirrhosis. Ann Pharmacother, 39:908-12.
30. Garcia-Tsao G, Lee FY, Harden GE, et al. 1995. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology, 108:1835-41.
31. Garcia-Tsao G. 1992. Spontaneous bacterial peritonitis. Gastroenterol Clin N Am, 21:257-75.
32. Ginès P, Martin PY, Neiderbeger M. 1997. Prognostic signifcance of renal dysfunction in cirrhosis. Kidney Int Suppl, 61:s77-82.
33. Ginès P, Rimola A, Planas R, et al. 1990. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology, 12:716-24.
34. Grangé JD, Amiot X, Grange V, et al. 1990. Amoxicillin+clavulinic acid therapy of spontaneous bacterial peritonitis: a prospective study of twenty-seven cases in cirrhotic patients. Hepatology, 11:360-4.
35. Grangé JD, Roulot D, Pelletier G, et al. 1998. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites. A double-blind randomized trial. J Hepatol, 29:430-6.
36. Guarner C, Runyon BA. 1995. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management. Gastroenterologist, 3:311-28.
37. Guarner C, Solà R, Soriano G, et al. 1999. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology, 117:414-19.
38. Homann C, Varming K, Hogasen K, et al. 1997. Acquired C3 deficiency in patients with alcoholic cirrhosis predisposes to infection and increased mortality. Gut, 40:544-9.
39. Hou MC, Lin HC, Liu TT, et al. 2004. Antibiotic prophylaxis after endoscopic therapy prevents rebleeding in acute variceal hemorrhage: a randomized trial. Hepatology, 39:746-53.
40. Hurwich DB, Lindor KD, Hay JE, et al. 1993. Prevalence of peritonitis and the ascitic fluid protein concentration among chronic liver disease patients. Am J Gastroenterol, 88:1254-7.
41. Jalan R, Hayes PC. 2000. BSG guidelines on variceal bleeding. Gut, 46(Suppl. 3-4): III1-15.
42. Javid G, Khan BA, Khan BA, et al. 1998. Short-course ceftriaxone therapy in spontaneous bacterial peritonitis. Postgrad Med J, 74:592-5.
43. Jeffries MA, Stern MA, Gunaratnam NT, et al. 1999. Unsuspected infection is infrequent in asymptomatic outpatients with refractory ascites undergoing therapeutic paracenteses. Am J Gastroenterol, 94:2972-6.
44. Kerr DNS, Pearson DT, Read AE. 1963. Infection of ascitic fluid in patients with hepatic cirrhosis. Gut, 4:394-8.
45. Kim do Y, Kim JH, Chon CY, et al. 2005. Usefulness of urine strip test in the rapid diagnosis of spontaneous bacterial peritonitis. Liver Int, 25:1197-201.
46. Krencker E. 1907. [Bacterium coli commune als Sepsiserreger in 2 fallen von abdominaler krankungen.] Munchen Med Wschr, 54:2095.
47. Llach J, Rimola A, Navasa M, et al. 1992. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology, 16:724-7.
48. Llovet J, Rodriguez-Iglesias P, Moitinho E, et al. 1997. Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol, 26:88-95.
49. Lontos S, Gow PJ, Vaughan RB et al. 2008. Norfloxacin and trimethoprim-sulfamethoxazole therapy have similar efficacy in prevention of spontaneous bacterial peritonitis. J Gastroenterol Hepatol, 23:252-5.
50. Mattos A. 1994. [Peritonite bacteriana espontânea e suas variantes; epidemiologia diagnóstico e história natural.] GED, 13:97-105.
51. Moore KP, Wong F, Gines P, et al. 2003. The management of ascites in cirrhosis: report on the consensus conference of international ascites club. Hepatology, 38:258-66.
52. Moosa AA, Quortum HA, Ibrahim MD. 1995. Rapid diagnosis of bacterial meningitis with reagent strips. Lancet, 345:1290-1.
53. Navasa M, Fernandez J, Rodes J. 1999. Bacterial infections in liver cirrhosis. Ital J Gastroenterol Hepatol, 31:616-25.
54. Navasa M, Follo A, Llovet JM, et al. 1996. Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology, 111:1011-17.
55. Nousbaum JB, Cadranel JF, Nahon P, et al. 2007. Diagnostic accuracy of the Multistix 8 SG reagent strip in diagnosis of spontaneous bacterial peritonitis. Hepatology, 45:1275-81.
56. Novella M, Solà R, Soriano G, et al. 1997. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology, 25:532-6.
57. Pardo A, Bartoli R, Lorenzo-Zuniga V, et al. 2000. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology, 31:858-63.
58. Perez-Paramo M, Munoz J, Albillos A, et al. 2000. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology, 31:43-8.
59. Rerknimitr R, Rungsangmanoon W, Kongkam P, et al. 2006. Efficacy of leukocyte esterase dipstick test as a rapid test in diagnosis of spontaneous bacterial peritonitis. World J Gastroenterol, 12:7183-7.
60. Ribeiro TC, Kondo M, Amaral AC, et al. 2007. Evaluation of reagent strips for ascitic fluid leukocyte determination: is it a possible alternative for spontaneous bacterial peritonitis rapid diagnosis? Braz J Infect Dis, 11:70-4.
61. Rimola A, Bory F, Teres J, et al. 1985. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology, 5:463-7.
62. Rimola A, Garcia-Tsao G, Navasa M, et al. 2000. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. J Hepatol, 32:142-53.
63. Rimola A, Navasa M, Arroyo V. 1995. Experience with cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis. Diagn Microbiol Infect Dis, 22:141-5.
64. Rimola A, Salmeron JM, Clemente G, et al. 1995. Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: Results of a prospective, randomized, multicenter study. Hepatology, 21:674-9.
65. Runyon BA, Morrissey RL, Hoefs JC, et al. 1985. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology, 5:634-7.
66. Runyon BA, Umland ET, Merli T. 1987. Inoculation of blood culture bottles with ascitic fluid-improved detection of spontaneous bacterial peritonitis. Arch Intern Med, 147:73-5.
67. Runyon BA. 1986. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology, 91:1343-6.
68. Runyon BA. 1999. Albumin infusion for spontaneous bacterial peritonitis. Lancet, 354:1838-9.
69. Runyon BA. 2004. Early events in spontaneous bacterial peritonitis. Gut, 63:782-4.
70. Salerno F, Gerbes A, Ginès P, et al. 2007. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut, 56:1310-18.
71. Sapey T, Mena E, Fort E, et al. 2005a. Rapid diagnosis of spontaneous bacterial peritonitis with leukocyte esterase reagent strips in a European and in an American center. J Gastroentetol Hepatol, 20:187-92.
72. Sapey T, Kabissa D, Fort E, et al. 2005b. Instant diagnosis of spontaneous bacterial peritonitis using leukocyte esterase reagent strips: Nephur-Tests vs. MultistixSG. Liver Int, 25:343-8.
73. Sarwar S, Alam A, Izhar M, et al. 2005. Bedside diagnosis of spontaneous peritonitis using reagent strips. J Coll Physicians Surg Pak, 15:418-21.
74. Sette Jr H, Mies S, Barros MFA, et al. 1996. [Peritonite bacteriana espontânea.] Rev Paul Med, 104:292-7.
75. Singh N, Wagener MM, Gayoski T. 2003. Changing epidemiology and predictors of mortality in patents with spontaneous bacterial peritonitis at liver transplant unit. Clin Microbiol Infect, 9:531-7.
76. Soriano G, Guarner C, Tomas A, et al. 1992. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology, 103:1267-72.
77. Sort P, Navasa M, Arroyo V, et al. 1999. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med, 341:403-9.
78. Such J, Runyon BA. 1998. Spontaneous bacterial peritonitis. Clin Infect Dis, 27:669-74
79. Terg R, Cobas S, Fassio E, et al. 2000. Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter randomized study. J Hepatol, 33:564-9.
80. Thèvenot T, Cadranel JF, Nguyen-Khac E, et al. 2004. Diagnosis of spontaneous bacterial peritonitis in cirrhotic patients by use of two reagent strips. Eur J Gastroenterol Hepatol, 16:579-83.
81. Thuluvath PJ, Morss S, Thompson R. 2001. Spontaneous bacterial peritonitis - In-hospital mortality, predictors of survival, and health care costs from 1988 to 1998. Am J Gastroenterol, 96:1232-6.
82. Tito L, Rimola A, Ginès P, et al. 1988. Recurrence of spontaneous in cirrhosis: frequency and predictive factors. Hepatology, 8:27-31.
83. Torun S, Dolar E, Yilmaz Y, et al. 2007. Evaluation of leukocyte esterase and nitrite strip tests to detect spontaneous bacterial peritonitis in cirrhotic patients. World J Gastroenterol, 13:6027-30.
84. Vanbiervliet G, Rakotoarisoa C, Filippi J, et al. 2002. Diagnostic accuracy of a rapid urine-screening test (Multistix8SG) in cirrhotic patients with spontaneous bacterial peritonitis. Eur J Gastroenterol Hepatol, 14:1257-60.
85. Wisniewski B, Rautou PE, Al Sirafi Y, et al. 2005. Diagnosis of spontaneous ascites infection in patients with cirrhosis: reagent strips. Presse Med, 34:997-1000.